127 related articles for article (PubMed ID: 37909982)
21. Potential noninvasive biomarkers for the malignant transformation of oral leukoplakia: A systematic review and meta-analysis.
Huang Y; Zhang Q; Guo Z; Deng G; Chen R; Zheng Y
Cancer Med; 2023 Jul; 12(13):14718-14730. PubMed ID: 37199052
[TBL] [Abstract][Full Text] [Related]
22. Podoplanin Expression Independently and Jointly with Oral Epithelial Dysplasia Grade Acts as a Potential Biomarker of Malignant Transformation in Oral Leukoplakia.
Monteiro L; do Amaral B; Delgado L; Garcês F; Salazar F; Pacheco JJ; Lopes C; Warnakulasuriya S
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625534
[TBL] [Abstract][Full Text] [Related]
23. Predictors of malignant transformation in oral leukoplakia and proliferative verrucous leukoplakia: An observational prospective study including the DNA ploidy status.
Pentenero M; Castagnola P; Castillo FV; Isaevska E; Sutera S; Gandolfo S
Head Neck; 2023 Oct; 45(10):2589-2604. PubMed ID: 37563936
[TBL] [Abstract][Full Text] [Related]
24. An immunohistochemical evaluation of podoplanin expression in oral leukoplakia and oral squamous cell carcinoma to explore its potential to be used as a predictor for malignant transformation.
Aiswarya A; Suresh R; Janardhanan M; Savithri V; Aravind T; Mathew L
J Oral Maxillofac Pathol; 2019; 23(1):159. PubMed ID: 31110440
[TBL] [Abstract][Full Text] [Related]
25. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
26. High density of CD8 T cell and immune imbalance of T lymphocytes subsets are associated with proliferative verrucous leukoplakia.
Fernandes D; Barbeiro CO; Palaçon MP; Biancardi MR; Ferrisse TM; Silveira HA; Castilho RM; de Almeida LY; Leon JE; Bufalino A
Immunology; 2023 Jan; 168(1):96-109. PubMed ID: 36056642
[TBL] [Abstract][Full Text] [Related]
27. MAGE-A expression in oral and laryngeal leukoplakia predicts malignant transformation.
Baran CA; Agaimy A; Wehrhan F; Weber M; Hille V; Brunner K; Wickenhauser C; Siebolts U; Nkenke E; Kesting M; Ries J
Mod Pathol; 2019 Jul; 32(8):1068-1081. PubMed ID: 30936424
[TBL] [Abstract][Full Text] [Related]
28. BMI-1 expression increases in oral leukoplakias and correlates with cell proliferation.
Klein IP; Meurer L; Danilevicz CK; Squarize CH; Martins MD; Carrard VC
J Appl Oral Sci; 2020; 28():e20190532. PubMed ID: 32348447
[TBL] [Abstract][Full Text] [Related]
29. Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review.
Monteiro L; Mello FW; Warnakulasuriya S
Oral Dis; 2021 Nov; 27(8):1977-1992. PubMed ID: 33290585
[TBL] [Abstract][Full Text] [Related]
30. Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma.
Ding X; Zheng Y; Wang Z; Zhang W; Dong Y; Chen W; Li J; Chu W; Zhang W; Zhong Y; Mao L; Song X; Wu Y
Oncol Rep; 2018 Jun; 39(6):2584-2594. PubMed ID: 29620248
[TBL] [Abstract][Full Text] [Related]
31. Association between histopathological features of dysplasia in oral leukoplakia and loss of heterozygosity.
Fonseca-Silva T; Diniz MG; de Sousa SF; Gomez RS; Gomes CC
Histopathology; 2016 Feb; 68(3):456-60. PubMed ID: 26042642
[TBL] [Abstract][Full Text] [Related]
32. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
33. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
34. The genetic basis of oral leukoplakia and its key role in understanding oral carcinogenesis.
Guimarães LM; Diniz MG; Rogatto SR; Gomez RS; Gomes CC
J Oral Pathol Med; 2021 Aug; 50(7):632-638. PubMed ID: 33217066
[TBL] [Abstract][Full Text] [Related]
35. Inter- and intra-lesional molecular heterogeneity of oral leukoplakia.
Gomes CC; Fonseca-Silva T; Galvão CF; Friedman E; De Marco L; Gomez RS
Oral Oncol; 2015 Feb; 51(2):178-81. PubMed ID: 25467776
[TBL] [Abstract][Full Text] [Related]
36. Oral leukoplakia: A clinicopathological study and malignant transformation.
Tovaru S; Costache M; Perlea P; Caramida M; Totan C; Warnakulasuriya S; Parlatescu I
Oral Dis; 2023 May; 29(4):1454-1463. PubMed ID: 34982498
[TBL] [Abstract][Full Text] [Related]
37. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
38. EZH2 Expression Correlates With T-Cell Infiltration in Oral Leukoplakia and Predicts Cancer Transformation.
Ganesh D; Dafar A; Niklasson J; Sandberg I; Braz-Silva P; Sapkota D; Öhman J; Giglio D; Hasséus B
Anticancer Res; 2023 Apr; 43(4):1533-1542. PubMed ID: 36974822
[TBL] [Abstract][Full Text] [Related]
39. Identification of Proteomic Biomarkers in Proliferative Verrucous Leukoplakia through Liquid Chromatography With Tandem Mass Spectrometry.
Arroyo E; Pérez Sayáns M; Bravo SB; de Oliveira Barbeiro C; Paravani Palaçon M; Chamorro Petronacci CM; García Vence M; Chantada Vázquez MDP; Blanco Carrión A; Suárez Peñaranda JM; García García A; Gándara Vila P; Días Almeida J; Veríssimo da Costa GC; Sousa Nogueira FC; Medeiros Evaristo JA; de Abreu Pereira D; Rintala M; Salo T; Rautava J; Padín Iruegas E; Oliveira Alves MG; Morandin Ferrisse T; Albergoni da Silveira H; Esquiche León J; Vilela Silva E; Flores IL; Bufalino A
Lab Invest; 2023 Oct; 103(10):100222. PubMed ID: 37507024
[TBL] [Abstract][Full Text] [Related]
40. ALDH1 and podoplanin expression patterns predict the risk of malignant transformation in oral leukoplakia.
Habiba U; Hida K; Kitamura T; Matsuda AY; Higashino F; Ito YM; Ohiro Y; Totsuka Y; Shindoh M
Oncol Lett; 2017 Jan; 13(1):321-328. PubMed ID: 28123562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
